Gep Net | List of Frontiers open access articles

Original Research

Published on 18 Mar 2021

Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors

in Cancer Endocrinology

Luigi Barrea
Giovanna Muscogiuri
Roberta Modica
Barbara Altieri
Gabriella Pugliese
Roberto Minotta
Antongiulio Faggiano
Annamaria Colao
Silvia Savastano

Frontiers in Endocrinology

doi 10.3389/fendo.2021.649496

9,172 views
47 citations

Original Research

Published on 20 Jan 2023

HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors

in Cancer Endocrinology

Chiara Liverani
Chiara Spadazzi
Toni Ibrahim
Federica Pieri
Flavia Foca
Chiara Calabrese
Alessandro De Vita
Giacomo Miserocchi
Claudia Cocchi
Silvia Vanni

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1045038

4,587 views
5 citations

Original Research

Published on 12 Nov 2021

The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hui-Jen Tsai
Chin-Fu Hsiao
Jeffrey S. Chang
Li-Tzong Chen
Ying-Jui Chao
Chia-Ju Yen
Yan-Shen Shan

Frontiers in Oncology

doi 10.3389/fonc.2021.741096

34,193 views
28 citations

Original Research

Published on 23 May 2023

Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors

in Cancer Imaging and Image-directed Interventions

Martine Bocchini
Marcella Tazzari
Sara Ravaioli
Filippo Piccinini
Flavia Foca
Michela Tebaldi
Fabio Nicolini
Ilaria Grassi
Stefano Severi
Raffaele Adolfo Calogero

Frontiers in Oncology

doi 10.3389/fonc.2023.1136331

4,592 views
7 citations

Original Research

Published on 17 Jul 2020

Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades

in Gastrointestinal Cancers

Elisabetta Cavalcanti
Vanessa Galleggiante
Sergio Coletta
Elisa Stasi
Marcello Chieppa
Raffaele Armentano
Grazia Serino

Frontiers in Oncology

doi 10.3389/fonc.2020.01187

4,545 views
16 citations

Original Research

Published on 04 Dec 2018

Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study

in Cancer Endocrinology

Mark J. C. van Treijen
Catharina M. Korse
Rachel S. van Leeuwaarde
Lisette J. Saveur
Menno R. Vriens
Wieke H. M. Verbeek
Margot E. T. Tesselaar
Gerlof D. Valk

Frontiers in Endocrinology

doi 10.3389/fendo.2018.00740

5,253 views
52 citations

Original Research

Published on 14 Mar 2025

Prediction of lesion-based response to PRRT using baseline somatostatin receptor PET

in Nuclear Medicine

Anas Aouf
Tilman Speicher
Arne Blickle
Moritz B. Bastian
Caroline Burgard
Florian Rosar
Samer Ezziddin
Amir Sabet

Frontiers in Medicine

doi 10.3389/fmed.2025.1523862

2,068 views

Articles

Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors

HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors

The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience

Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors

Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades

Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study

Prediction of lesion-based response to PRRT using baseline somatostatin receptor PET